Brendan P. O'Grady, EVP, North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 463 shares at $11.37 ($5K) on 2020-03-03, disclosed to the SEC on 2020-03-05.
Scheduled sale ($5k) by EVP, North America Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2021-03-04 | $332K | — | Filing → |
| TEVA | SELL | 2021-03-02 | $1.6M | — | Filing → |
| TEVA | SELL | 2021-02-11 | $525K | — | Filing → |